Similar articles for PMID: 33893075

Year	Number of Results
2007	1
2011	4
2012	8
2013	8
2014	8
2015	11
2016	9
2017	4
2018	8
2019	16
2020	20
2021	22
2022	12
2023	6
2024	0

1

G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma.

Chen SK, Wang YC, Lin TY, Wu HJ, Huang CJ, Ku WC. Chen SK, et al. Cancer Genomics Proteomics. 2021 May-Jun;18(3):207-220. doi: 10.21873/cgp.20253. Cancer Genomics Proteomics. 2021. PMID: 33893075 Free PMC article.

2

Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.

D'Amato C, Rosa R, Marciano R, D'Amato V, Formisano L, Nappi L, Raimondo L, Di Mauro C, Servetto A, Fulciniti F, Cipolletta A, Bianco C, Ciardiello F, Veneziani BM, De Placido S, Bianco R. D'Amato C, et al. Br J Cancer. 2014 Sep 9;111(6):1168-79. doi: 10.1038/bjc.2014.421. Epub 2014 Aug 5. Br J Cancer. 2014. PMID: 25093491 Free PMC article.

3

Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma.

Kuroshima K, Yoshino H, Okamura S, Tsuruda M, Osako Y, Sakaguchi T, Sugita S, Tatarano S, Nakagawa M, Enokida H. Kuroshima K, et al. Cancer Sci. 2020 May;111(5):1607-1618. doi: 10.1111/cas.14395. Epub 2020 May 5. Cancer Sci. 2020. PMID: 32232883 Free PMC article.

4

4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1.

Hirao-Suzuki M, Nagase K, Suemori T, Tsutsumi K, Shigemori E, Tanaka M, Takiguchi M, Sugihara N, Yoshihara S, Takeda S. Hirao-Suzuki M, et al. Biol Pharm Bull. 2021;44(10):1524-1529. doi: 10.1248/bpb.b21-00417. Biol Pharm Bull. 2021. PMID: 34602561 Free article.

5

Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.

Shi H, Sun Y, He M, Yang X, Hamada M, Fukunaga T, Zhang X, Chang C. Shi H, et al. Oncogene. 2020 Jan;39(3):530-545. doi: 10.1038/s41388-019-0962-8. Epub 2019 Sep 9. Oncogene. 2020. PMID: 31501521 Free PMC article.

6

Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects.

Kamli H, Owens EP, Vesey DA, Prasanna R, Li L, Gobe GC, Morais C. Kamli H, et al. Biochem Biophys Res Commun. 2022 Jan 1;586:42-48. doi: 10.1016/j.bbrc.2021.11.069. Epub 2021 Nov 20. Biochem Biophys Res Commun. 2022. PMID: 34826699

7

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.

D'Costa NM, Lowerison MR, Raven PA, Tan Z, Roberts ME, Shrestha R, Urban MW, Monjaras-Avila CU, Oo HZ, Hurtado-Coll A, Chavez-Munoz C, So AI. D'Costa NM, et al. J Exp Clin Cancer Res. 2020 Feb 10;39(1):33. doi: 10.1186/s13046-020-1527-y. J Exp Clin Cancer Res. 2020. PMID: 32041631 Free PMC article.

8

Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.

Sakai I, Miyake H, Fujisawa M. Sakai I, et al. BJU Int. 2013 Jul;112(2):E211-20. doi: 10.1111/j.1464-410X.2012.11655.x. Epub 2013 Jan 10. BJU Int. 2013. PMID: 23305097

9

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.

Liu Y, Cheng G, Huang Z, Bao L, Liu J, Wang C, Xiong Z, Zhou L, Xu T, Liu D, Yang H, Chen K, Zhang X. Liu Y, et al. Cell Death Dis. 2020 Jul 8;11(7):515. doi: 10.1038/s41419-020-2713-8. Cell Death Dis. 2020. PMID: 32641718 Free PMC article.

10

Splice variants of lysosome‑associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells.

Nishikawa R, Osaki M, Sasaki R, Ishikawa M, Yumioka T, Yamaguchi N, Iwamoto H, Honda M, Kabuta T, Takenaka A, Okada F. Nishikawa R, et al. Oncol Rep. 2020 Nov;44(5):1810-1820. doi: 10.3892/or.2020.7752. Epub 2020 Sep 4. Oncol Rep. 2020. PMID: 32901843 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

123 results

Results by year